Literature DB >> 21680202

Comparison of Ponseti versus surgical treatment in congenital talipes equinovarus.

Nicholas M P Clarke1, Michael G Uglow, Katy M Valentine.   

Abstract

In the present study we compared the rate of relapse after conservative Ponseti treatment method with that of a historical cohort who underwent conventional operative treatment. From June 2002 to December 2004, 70 patients presented with 107 clubfeet and started Ponseti treatment. Of these 70 patients, 9 (15 feet) were excluded because of a teratologic deformity. Thus, 50 patients with 75 clubfeet were studied (41 [82%] boys and 9 [18%] girls). Data were compiled from the clinic assessment forms and patient notes. All cases resulting in recasting or additional operative procedures were regarded as failure of conservative treatment. The minimum follow-up period was 2 years or failure of the Ponseti method within this period. These data were then compared with the published data from the same center, regarding relapse after the 2-stage operative method. From 1988 to 1995, 86 patients had presented with 120 clubfeet and undergone operative treatment. Of the 86 patients, 68 (91 clubfeet; 48 boys and 20 girls) underwent the 2-stage operative procedure and were followed up to a mean age of 5.7 (range 2.2 to 9.6) years. The mean age at operative treatment was 8.9 months. The relapse rate of both treatment methods was compared for all feet in all Dimeglio grades. The relapse rate for Ponseti versus surgery was 18.2% versus 0% for grade 2, 36.2% versus 20.4% for grade 3, and 35.3% versus 65.4% for grade 4, respectively. No statistically significant difference was found. The Ponseti method is as valid as the 2-stage operative method for the treatment of clubfoot. The functional outcomes of the 2 treatment methods need to be compared.
Copyright © 2011 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21680202     DOI: 10.1053/j.jfas.2011.04.040

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  7 in total

1.  [Minimally invasive treatment of congenital foot deformities in infants: new findings and midterm-results].

Authors:  O Eberhardt; T Wirth; F F Fernandez
Journal:  Orthopade       Date:  2013-12       Impact factor: 1.087

Review 2.  Results of clubfoot management using the Ponseti method: do the details matter? A systematic review.

Authors:  Dahang Zhao; Hai Li; Li Zhao; Jianlin Liu; Zhenkai Wu; Fangchun Jin
Journal:  Clin Orthop Relat Res       Date:  2014-01-17       Impact factor: 4.176

3.  Idiopathic clubfoot: ten year follow-up after a soft tissue release procedure.

Authors:  Noppachart Limpaphayom; Stephen J Kerr; Pairatch Prasongchin
Journal:  Int Orthop       Date:  2014-09-18       Impact factor: 3.075

4.  Midterm results of the Ponseti method in the treatment of congenital clubfoot.

Authors:  Christof Radler; Gabriel T Mindler; Karin Riedl; Charlotte Lipkowski; Andreas Kranzl
Journal:  Int Orthop       Date:  2013-07-31       Impact factor: 3.075

5.  [Clubfoot treatment through the ages: the Ponseti method in comparison to other conservative approaches and operative procedures].

Authors:  H Delbrück; M Schaltenbrand; S Schröder; M Rauschmann; C Schwenninger
Journal:  Orthopade       Date:  2013-06       Impact factor: 1.087

6.  Guideline on the diagnosis and treatment of primary idiopathic clubfoot.

Authors:  Arnold T Besselaar; Ralph J B Sakkers; Hans A Schuppers; Melinda M E H Witbreuk; Elgun V C M Zeegers; Jan D Visser; Robert A Boekestijn; Sacha D Margés; M C Marieke Van der Steen; Koert N J Burger
Journal:  Acta Orthop       Date:  2017-03-07       Impact factor: 3.717

7.  Prognostic factors for recurrent idiopathic clubfoot deformity: a systematic literature review and meta-analysis.

Authors:  Heleen Van Schelven; Sophie Moerman; Marieke Van der Steen; Arnold T Besselaar; Christian Greve
Journal:  Acta Orthop       Date:  2022-01-03       Impact factor: 3.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.